Perrigo - 33 Year Stock Price History | PRGO
Historical daily share price chart and data for Perrigo since 1991 adjusted for splits and dividends. The latest closing stock price for Perrigo as of April 26, 2024 is 31.94.
- The all-time high Perrigo stock closing price was 174.85 on April 14, 2015.
- The Perrigo 52-week high stock price is 40.28, which is 26.1% above the current share price.
- The Perrigo 52-week low stock price is 25.77, which is 19.3% below the current share price.
- The average Perrigo stock price for the last 52 weeks is 32.43.
| Perrigo Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 31.2413 | 32.8645 | 33.8256 | 25.9884 | 31.9400 | 0.18% |
| 2023 | 33.0468 | 33.7649 | 38.9171 | 26.4940 | 31.8836 | -2.47% |
| 2022 | 35.5480 | 36.6046 | 40.5983 | 29.8428 | 32.6909 | -9.80% |
| 2021 | 39.9412 | 40.6221 | 45.2424 | 33.1775 | 36.2413 | -10.96% |
| 2020 | 46.1897 | 45.8796 | 54.3864 | 36.5289 | 40.7041 | -11.92% |
| 2019 | 43.8370 | 35.6050 | 50.5106 | 35.0512 | 46.2106 | 35.65% |
| 2018 | 66.2722 | 78.2625 | 83.0268 | 32.0885 | 34.0666 | -55.21% |
| 2017 | 67.6672 | 74.8587 | 77.5269 | 57.3609 | 76.0548 | 5.59% |
| 2016 | 90.1118 | 122.5906 | 128.2341 | 69.0762 | 72.0288 | -42.14% |
| 2015 | 147.6611 | 142.9237 | 174.8542 | 124.1219 | 124.4833 | -13.18% |
| 2014 | 129.5122 | 130.9530 | 144.7506 | 108.5873 | 143.3783 | 9.23% |
| 2013 | 106.5896 | 91.0100 | 134.1862 | 84.6476 | 131.2609 | 47.94% |
| 2012 | 91.0566 | 83.7864 | 102.2290 | 79.1784 | 88.7243 | 7.25% |
| 2011 | 73.3336 | 53.9801 | 87.1192 | 53.5225 | 82.7237 | 54.17% |
| 2010 | 48.8006 | 34.0317 | 57.6149 | 31.8641 | 53.6581 | 59.73% |
| 2009 | 24.8910 | 26.4550 | 34.4450 | 15.8458 | 33.5931 | 24.27% |
| 2008 | 28.9784 | 28.2773 | 35.2808 | 23.6054 | 27.0323 | -7.16% |
| 2007 | 17.7431 | 14.5215 | 30.0987 | 13.4267 | 29.1173 | 104.11% |
| 2006 | 13.3526 | 12.3691 | 15.2486 | 11.8456 | 14.2658 | 17.27% |
| 2005 | 12.6376 | 13.7127 | 15.9684 | 10.4613 | 12.1651 | -12.72% |
| 2004 | 15.2213 | 12.7213 | 18.6116 | 12.6332 | 13.9387 | 10.69% |
| 2003 | 11.1180 | 9.9263 | 13.1000 | 8.6176 | 12.5931 | 30.42% |
| 2002 | 9.4322 | 9.7276 | 11.6747 | 7.5262 | 9.6561 | 2.79% |
| 2001 | 10.2377 | 6.5566 | 14.5358 | 6.5073 | 9.3938 | 42.74% |
| 2000 | 5.6025 | 6.4533 | 7.2027 | 4.0977 | 6.5812 | 3.51% |
| 1999 | 6.5883 | 7.0533 | 7.6494 | 5.7619 | 6.3579 | -9.22% |
| 1998 | 8.1178 | 11.2297 | 11.3250 | 5.9605 | 7.0040 | -34.13% |
| 1997 | 10.2255 | 7.1527 | 13.5106 | 7.1527 | 10.6336 | 46.71% |
| 1996 | 8.6577 | 9.6322 | 11.3250 | 6.9540 | 7.2480 | -23.23% |
| 1995 | 9.7994 | 9.5369 | 11.0310 | 8.4481 | 9.4415 | -4.96% |
| 1994 | 14.4785 | 27.2198 | 27.2198 | 8.7421 | 9.9342 | -63.50% |
| 1993 | 20.2576 | 17.5836 | 27.2198 | 15.3981 | 27.2198 | 52.22% |
| 1992 | 13.2302 | 11.3250 | 17.8816 | 9.4892 | 17.8816 | 51.26% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.238B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.422B | 24.34 |
| Stryker (SYK) | United States | $128.275B | 31.81 |
| Boston Scientific (BSX) | United States | $107.479B | 34.23 |
| Medtronic (MDT) | Ireland | $105.230B | 14.90 |
| EssilorLuxottica (ESLOY) | France | $98.467B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.075B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.356B | 30.00 |
| ResMed (RMD) | United States | $26.979B | 25.30 |
| Terumo (TRUMY) | Japan | $24.775B | 34.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.604B | 15.84 |
| Baxter (BAX) | United States | $20.430B | 14.90 |
| Koninklijke Philips (PHG) | Netherlands | $19.242B | 15.35 |
| Insulet (PODD) | United States | $11.496B | 60.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.440B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.860B | 23.42 |
| BellRing Brands (BRBR) | United States | $7.238B | 38.92 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.452B | 22.77 |
| GN Store Nord (GNNDY) | Denmark | $3.889B | 25.18 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.47 |
| Envista Holdings (NVST) | United States | $3.441B | 13.09 |
| QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
| Neogen (NEOG) | United States | $2.591B | 24.92 |
| Green Thumb Industries (GTBIF) | United States | $2.482B | 78.67 |
| ICU Medical (ICUI) | United States | $2.303B | 17.19 |
| TG Therapeutics (TGTX) | United States | $2.150B | 695.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.906B | 0.00 |
| Owens & Minor (OMI) | United States | $1.848B | 17.74 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.617B | 0.00 |
| InMode (INMD) | Israel | $1.429B | 7.40 |
| LeMaitre Vascular (LMAT) | United States | $1.414B | 46.66 |
| National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
| AdaptHealth (AHCO) | United States | $1.273B | 9.58 |
| Warby Parker (WRBY) | United States | $1.254B | 0.00 |
| AtriCure (ATRC) | United States | $1.094B | 0.00 |
| MacroGenics (MGNX) | United States | $0.899B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.872B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.686B | 14.82 |
| Cresco Labs (CRLBF) | United States | $0.674B | 0.00 |
| Evolus (EOLS) | United States | $0.664B | 0.00 |
| Jin Medical (ZJYL) | China | $0.608B | 0.00 |
| Quanterix (QTRX) | United States | $0.596B | 0.00 |
| Valneva SE (VALN) | France | $0.526B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.504B | 10.91 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| TerrAscend (TSNDF) | Canada | $0.462B | 0.00 |
| ZimVie (ZIMV) | United States | $0.421B | 25.80 |
| Biote (BTMD) | United States | $0.416B | 3.96 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.66 |
| Surmodics (SRDX) | United States | $0.373B | 40.26 |
| Aurora Cannabis (ACB) | Canada | $0.366B | 0.00 |
| Zynex (ZYXI) | United States | $0.352B | 40.52 |
| Viemed Healthcare (VMD) | United States | $0.310B | 30.81 |
| Cerus (CERS) | United States | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.266B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.73 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Veru (VERU) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| High Tide (HITI) | Canada | $0.161B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 70.99 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.120B | 20.31 |
| Fonar (FONR) | United States | $0.107B | 9.16 |
| MariMed (MRMD) | United States | $0.100B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.59 |
| Apyx Medical (APYX) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Bright Green (BGXX) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 74.09 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |